臨床分子病態検査学講座

Keyphrases

1. 17-hydroxyprogesterone (17-OHP) 18%
2. Accreditation 18%
3. Adenosine Triphosphate 37%
4. Adenosine Triphosphate Bioluminescence 18%
5. Amniotic Fluid 46%
6. Amniotic Fluid Infection 21%
7. Amniotic Fluid Sludge 18%
8. Antibiotic Therapy 21%
9. Antibody Level 19%
10. Antigen Levels 18%
11. Antithrombin 22%
12. Antithrombin Deficiency 42%
13. Bacteremia 47%
14. Bacterial DNA 26%
15. Bacterial Infection 21%
16. Bivalent Vaccine 18%
17. Bleeding Disorders 20%
18. Bleeding Risk 18%
19. Blood Culture 30%
20. Blood Culture Bottles 18%
21. Blood Samples 27%
22. Candida Species 18%
23. Casirivimab 18%
24. Casirivimab-imdevimab 18%
25. Catheter-directed Thrombolysis 18%
26. Cell Population Data 18%
27. Cerebrospinal Fluid 37%
28. Clinical Laboratory 58%
29. Cortical Vein Thrombosis 18%
30. COVID-19 46%
31. DNA Contamination 25%
32. Eukaryotes 51%
33. Fluorescence Correlation Spectroscopy 24%
34. Genetic Diagnostics 18%
35. Growth Arrest 20%
36. Hematology Analyzer 18%
37. Hereditary Hemochromatosis 18%
38. High-throughput 21%
39. Highly Sensitive 27%
40. Huh7 18%
41. Hypervirulent Klebsiella Pneumoniae 18%
42. Imdevimab 18%
43. In Vivo Evidence 18%
44. Intact Membrane 27%
45. Intra-amniotic 24%
46. Intrauterine Inflammation 56%
47. ISO 15189 18%
48. Japan 23%
49. Klebsiella Pneumoniae (K. pneumoniae) 18%
50. Laboratory Examination 23%
51. Leg Edema 18%
52. Levofloxacin Resistance 18%
53. Loop-mediated Isothermal Amplification Assay 21%
54. Magnetic Resonance Imaging 22%
55. Male DNA 37%
56. Mapping Method 100%
57. Melting Temperature 93%
58. Mesenchymal Cells 37%
59. Microbes 21%
60. Microorganisms 33%
61. Mitochondrial Myopathy 18%
62. Multiple Sclerosis 18%
63. Mycoplasma 37%
64. Neutralizing Activity 33%
65. Neutralizing Antibodies 37%
66. Notch Signaling 18%
67. Omicron BA.5 19%
68. Omicron Variant 29%
69. Parvimonas Micra 18%
70. Pathogenic Microorganisms 42%
71. Perinatal Prognosis 21%
72. Polymerase Chain Reaction 21%
73. Polymicrobial 18%
74. Popliteal Vein 18%
75. Potential Biomarkers 19%
76. Preterm Labor 82%
77. Quantification Assay 18%
78. Quenching Probe 20%
79. Rapid Detection 31%
80. Rapid Identification 57%
81. Recombinase Polymerase Amplification 49%
82. S. Exigua 18%
83. SARS-CoV-2 Infection 25%
84. Second Booster 18%
85. Sepsis 32%
86. Slackia Exigua 18%
87. Sludge 18%
88. Splicing Abnormality 18%
89. Spondylodiscitis 18%
90. Stroke-like Episode 18%
91. Sysmex XN 18%
92. Temperature Mapping 100%
93. Testing System 18%
94. Thermostable DNA Polymerase 51%
95. Transforming Growth Factor-β 37%
96. Type I Interferon 18%
97. University Hospital 40%
98. Ureaplasma 37%
99. Week of Gestation 21%
100. XN-series 18%

Medicine and Dentistry

1. Amnion Fluid 23%
2. Antibiotic Therapy 22%
3. Antibody Response 9%
4. Anticoagulant Therapy 15%
5. Antiinfective Agent 10%
6. Antithrombin 20%
7. Antithrombin III Deficiency 46%
8. Apoplexy 9%
9. Arm 9%
10. Bacterial DNA 18%
11. Bacterial Infection 30%
12. Bayley Scales of Infant Development 14%
13. Biopsy Technique 9%
14. Bleeding 15%
15. Bleeding Disorder 20%
16. Blood Clot Lysis 18%
17. Blood Clotting Factor 10 Deficiency 9%
18. Blood Clotting Factor 7 Deficiency 18%
19. Blood Culture 24%
20. Bloodstream Infection 29%
21. Bone Biopsy 18%
22. Case Presentation 12%
23. Cell Line 18%
24. Cell Population 9%
25. Cerebral Venous Sinus Thrombosis 18%
26. COVID-19 18%
27. Decision Making 9%
28. Deep Vein Thrombosis 18%
29. Developmental Disorder 9%
30. Diagnosis 10%
31. Disease 9%
32. DNA Polymerase 27%
33. Eye Infection 18%
34. Factor X 18%
35. Fluorescence Analysis 9%
36. Gestation Period 18%
37. Gram Positive Cocci 9%
38. Gram Staining 9%
39. Growth Disorder 18%
40. Halomonas 9%
41. Hematology 9%
42. Hemiparesis 9%
43. Hemochromatosis 18%
44. Hemostat 14%
45. Hypoxemia 9%
46. Immunity 9%
47. Infection 55%
48. Infusion 12%
49. Interleukin 6 18%
50. Intervertebral Disk Degeneration 18%
51. Klebsiella pneumoniae 18%
52. Laboratory Test 23%
53. Leg Edema 12%
54. Loop-Mediated Isothermal Amplification 18%
55. Low Back Pain 9%
56. Lymphadenitis 9%
57. Magnetic Resonance Imaging 37%
58. Magnetic Resonance Venography 18%
59. Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry 13%
60. Maturity Onset Diabetes of the Young 9%
61. Messenger RNA 22%
62. Methicillin Resistant Staphylococcus Aureus 12%
63. Methicillin Resistant Staphylococcus Aureus Infection 9%
64. Multiple Sclerosis 18%
65. Neutralizing Antibody 9%
66. Nonsense Mutation 18%
67. Omicron Coronavirus Variant 11%
68. Open Heart Surgery 18%
69. Panton Valentine Leukocidin 9%
70. Paresthesia 15%
71. Parietal Lobe 9%
72. Parvimonas micra 18%
73. Pathogen 10%
74. Pediatrics 9%
75. Pediatrics Patient 9%
76. Phlebothrombosis 18%
77. Pneumococcus 18%
78. Polymerase 9%
79. Polymerase Chain Reaction 21%
80. Popliteal Vein 12%
81. Pre-Eclampsia 18%
82. Pregnancy 23%
83. Premature Labor 42%
84. Prospective Study 9%
85. Pyogenic Liver Abscess 18%
86. Real-Time Polymerase Chain Reaction 10%
87. Recombinase 9%
88. Renal Cyst 18%
89. Respiratory Failure 9%
90. Retrospective Study 14%
91. Reverse Transcription 9%
92. Sagittal Sinus Thrombosis 9%
93. Sepsis 28%
94. Severe Acute Respiratory Syndrome Coronavirus 2 9%
95. Single Isomorphous Replacement 18%
96. Spastic Diplegia 9%
97. Substitution Therapy 12%
98. T Follicular Helper Cell 9%
99. Thrombosis 10%
100. Thrombus 12%